Singular Genomics Systems Ownership | Who Owns Singular Genomics Systems?
Singular Genomics Systems Ownership Summary
Singular Genomics Systems is owned by 34.51% institutional investors, and 65.49% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of OMIC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.58% of its assets in Singular Genomics Systems shares.
OMIC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Singular Genomics Systems | 34.51% | - | 65.49% |
Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
Industry | Medical Instruments & Supplies Stocks | 56.05% | 10.80% | 33.15% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Geode capital management | - | - | - |
Renaissance | - | - | - |
Engineers gate manager lp | - | - | - |
Blackrock | - | - | - |
Tower research capital llc (trc) | - | - | - |
Triatomic management lp | - | - | - |
Barclays | - | - | - |
Susquehanna group, llp | - | - | - |
Verition fund management | - | - | - |
Tikvah management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Geode capital management | - | - | - |
Renaissance | - | - | - |
Engineers gate manager lp | - | - | - |
Blackrock | - | - | - |
Tower research capital llc (trc) | - | - | - |
Triatomic management lp | - | - | - |
Barclays | - | - | - |
Susquehanna group, llp | - | - | - |
Verition fund management | - | - | - |
Tikvah management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Citigroup | - | - | -29.00 |
Harbour investments | - | - | -172.00 |
Wells fargo & company/mn | - | - | -384.00 |
Qube research | - | - | -682.00 |
Rhumbline advisers | - | - | -1.66K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deerfield management company, l.p. (series c) | - | - | -4.98M |
Arch venture management | - | - | -3.80M |
Qvidtvm management | - | - | -2.51M |
Ubs group | - | - | -2.21M |
Perceptive advisors | - | - | -2.13M |
Sold Out
Holder | Change |
---|---|
Citigroup | -29.00 |
Harbour investments | -172.00 |
Wells fargo & company/mn | -384.00 |
Qube research | -682.00 |
Rhumbline advisers | -1.66K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2024 | 43 | -8.51% | 25,384,404 | -3.12% | 34 | 2.69% | 10 | -16.67% | 10 | -28.57% |
Dec 31, 2023 | 47 | -2.08% | 26,201,129 | -2.99% | 35 | 2.58% | 12 | - | 14 | -30.00% |
Sep 30, 2023 | 48 | -22.58% | 27,007,538 | -17.78% | 37 | 1.79% | 12 | -60.00% | 20 | - |
Jun 30, 2023 | 62 | -7.46% | 32,847,914 | -8.33% | 45 | 1.84% | 30 | 42.86% | 20 | -9.09% |
Mar 31, 2023 | 67 | -16.25% | 35,832,078 | -3.66% | 49 | 1.82% | 21 | -48.78% | 22 | 4.76% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 39.34K | 1.58% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 21.64K | 0.87% | - |
Fidelity Extended Market Index | 10.11K | 0.40% | 781.00 |
Fidelity Total Market Index | 2.61K | 0.10% | - |
Fidelity Series Total Market Index | 2.35K | 0.09% | 372.00 |
NT Ext Equity Mkt Idx Fd - NL | 1.28K | 0.05% | -1.00 |
NT Ext Equity Mkt Idx Fd - L | 1.27K | 0.05% | - |
Northern Trust Extended Eq Market Idx | 1.27K | 0.05% | - |
Fidelity Nasdaq Composite Index | 1.25K | 0.05% | - |
Dimensional US Sustainability Core 1 ETF | 1.20K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 12, 2024 | Spaventa Andrew | Chief Executive Officer | Sell | $15.67K |
Sep 16, 2024 | TANG KEVIN | - | Buy | $642.30K |
Sep 17, 2024 | TANG KEVIN | - | Buy | $613.20K |
Sep 18, 2024 | TANG KEVIN | - | Buy | $550.72K |
Sep 15, 2024 | Spaventa Andrew | Chief Executive Officer | Sell | $2.17K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 1 |
2024 Q3 | 3 | 1 |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 3 | - |
OMIC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools